ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994

Wyngaarden Law With Appointment Report; DeVita Tells Congress “We’re Addressing The Issue Internally”

March 20, 1987

Roger Bonus Bill Wouldn’t Keep Rauscher

May 28, 1976

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

Intensity Modulated Therapy Safer Than Three-Dimensional Radiation

June 24, 2011

UC Breast Cancer ProgramTo Award $20 Million In Grants

December 16, 1994